MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT, Inc. (NASDAQ:XENT), a company seeking to improve the quality of life for patients with ear, nose and throat conditions, today announced that it plans to release third quarter financial results after market close on November 2, 2016. Management will hold a conference call to review the company’s third quarter 2016 performance at 4:30 p.m. ET on the same day.
